Sign up
Log in
Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Share
Listen to the news

Shares of Autodesk Inc (NASDAQ:ADSK) rose sharply in pre-market trading after the company reported third-quarter adjusted EPS and sales above analyst estimates.

Autodesk said third-quarter revenue increased 18% year-over-year to $1.85 billion, beating analyst estimates of $1.81 billion. The software company reported third-quarter adjusted earnings of $2.67 per share, beating estimates of $2.50 per share, according to Benzinga Pro.

Autodesk shares surged 6.1% to $312.50 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • Mobile-Health Network Solutions (NASDAQ:MNDR) surged 45.4% to $2.76 in pre-market trading. The Singapore-based company submitted a filing on Monday with the Securities and Exchange Commission (SEC) to increase its at-the-market offering capacity to $2.26 million from $1.25 million.
  • Inno Holdings Inc (NASDAQ:INHD) surged 29.5% to $0.35 in pre-market trading after dipping 44% on Tuesday. INNO Digital recently signed a memorandum of understanding with Megabyte Solutions to jointly develop applications of Web3 technology.
  • KALA BIO Inc (NASDAQ:KALA) gained 24.1% to $0.79 in pre-market trading. Last week, the Massachusetts-based biopharmaceutical company entered into a Securities Purchase Agreement with investor David Lazar to raise up to $6 million through a private placement, according to a Securities and Exchange Commission (SEC) Form 8-K filing.
  • Wellgistics Health Inc (NASDAQ:WGRX) gained 18.2% to $0.65 in pre-market trading. Datavault AI granted Wellgistics Health an exclusive license to its proprietary smart-contract intellectual property for use in Wellgistics’ pharmacychain and einsteinrx platforms.
  • Urban Outfitters Inc (NASDAQ:URBN) rose 17.4% to $80.19 in pre-market trading after the company reported third-quarter EPS and sales above analyst estimates.
  • Boqii Holding Ltd (NYSE:BQ) rose 11% to $1.95 in pre-market trading after declining 4% on Tuesday.
  • Nomadar Corp (NASDAQ:NOMA) rose 9.6% to $7.99 in pre-market trading after declining 10% on Tuesday.
  • Mesoblast Ltd (NASDAQ:MESO) gained 6.8% to $17.15 in pre-market trading. Jefferies analyst David Stanton, on Tuesday, upgraded Mesoblast from Hold to Buy.
  • Petco Health and Wellness Company Inc (NASDAQ:WOOF) gained 8.1% to $3.21 in pre-market trading after the company reported better-than-expected third-quarter EPS results.

Losers

  • Nutanix Inc (NASDAQ:NTNX) tumbled 16.8% to $48.86 in pre-market trading after the company reported worse-than-expected first-quarter financial results and cut its FY26 sales guidance below estimates.
  • Biomx Inc (NYSE:PHGE) declined 13.2% to $5.00 in pre-market trading after the company issued an update on BX004 Phase 2b trial in cystic fibrosis.
  • Kaixin Holdings (NASDAQ:KXIN) shares dipped 12.1% to $0.18 in pre-market trading. Kaixin announced a 1-for-30 reverse stock split, effective Dec. 1
  • Deswell Industries Inc (NASDAQ:DSWL) fell 11.5% to $3.28 in pre-market trading.
  • Pharmacyte Biotech Inc (NASDAQ:PMCB) fell 9% to $0.81 in pre-market trading. PharmaCyte Biotech shares jumped 37% on Tuesday after the company announced monetization of its stake in Femasys
  • Jiayin Group Inc – ADR (NASDAQ:JFIN) dipped 7.8% to $6.83 in pre-market trading.
  • Zscaler Inc (NASDAQ:ZS) fell 7.2% to $269.00 in pre-market trading as the company reported financial results for the first quarter.
  • Ambarella Inc (NASDAQ:AMBA) fell 6.7% to $84.84 in pre-market trading after posting quarterly results.
  • Pagerduty Inc (NYSE:PD) dipped 5.8% to $14.30 in pre-market trading after the company reported mixed third-quarter financial results and lowered its FY26 sales guidance below estimates.
  • HP Inc (NYSE:HPQ) fell 5.7% to $22.94 in pre-market trading after the company issued first-quarter EPS guidance with a midpoint below estimates.

Now Read This:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.